Cargando…

Overcoming Temozolomide Resistance in Glioblastoma via Enhanced NAD(+) Bioavailability and Inhibition of Poly-ADP-Ribose Glycohydrolase

SIMPLE SUMMARY: Glioblastoma is the most prevalent and lethal brain tumor type, often treated with the DNA alkylating agent temozolomide (TMZ). The cytotoxic DNA lesion O(6)-methylguanine only accounts for about 9% of the DNA lesions induced by TMZ. The other DNA lesions (>80%) are quickly repair...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianfeng, Koczor, Christopher A., Saville, Kate M., Hayat, Faisal, Beiser, Alison, McClellan, Steven, Migaud, Marie E., Sobol, Robert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331395/ https://www.ncbi.nlm.nih.gov/pubmed/35892832 http://dx.doi.org/10.3390/cancers14153572

Ejemplares similares

NAD(+) bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells
por: Li, Jianfeng, et al.
Publicado: (2021)

Oncogenic activity of poly (ADP-ribose) glycohydrolase
por: Marques, Maud, et al.
Publicado: (2018)

Live Cell Detection of Poly(ADP-Ribose) for Use in Genetic and Genotoxic Compound Screens
por: Koczor, Christopher A., et al.
Publicado: (2022)

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase
por: Slade, Dea, et al.
Publicado: (2011)

Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase
por: Burns, David M., et al.
Publicado: (2009)

Crystallographic and Biochemical Analysis of the Mouse Poly(ADP-Ribose) Glycohydrolase
por: Wang, Zhizhi, et al.
Publicado: (2014)

The Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase
por: Blenn, Christian, et al.
Publicado: (2011)

An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cells
por: James, Dominic I., et al.
Publicado: (2016)

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents
por: Matanes, Emad, et al.
Publicado: (2021)

Stability of centrosome numbers in poly(ADP-ribose) polymerase-1- and poly(ADP-ribose) glycohydrolase-deficient mouse ES cells
por: Ogino, Hideki, et al.
Publicado: (2004)

Host Cell Poly(ADP-Ribose) Glycohydrolase Is Crucial for Trypanosoma cruzi Infection Cycle
por: Vilchez Larrea, Salomé C., et al.
Publicado: (2013)

Fine-Tuning of Smad Protein Function by Poly(ADP-Ribose) Polymerases and Poly(ADP-Ribose) Glycohydrolase during Transforming Growth Factor β Signaling
por: Dahl, Markus, et al.
Publicado: (2014)

Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP-ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells
por: FENG, XIAOXING, et al.
Publicado: (2012)

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
por: Harrision, Daniel, et al.
Publicado: (2020)

Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca(2+) fluxes in oxidative cell death
por: Blenn, C., et al.
Publicado: (2010)

Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase
por: Gravells, Polly, et al.
Publicado: (2017)

Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD(+)/SIRT6 axis
por: Koczor, Christopher A., et al.
Publicado: (2021)

Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives
por: Tucker, Julie A., et al.
Publicado: (2012)

Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation
por: Li, Xuan, et al.
Publicado: (2016)

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors
por: Pillay, Nisha, et al.
Publicado: (2019)

Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities
por: Barkauskaite, Eva, et al.
Publicado: (2013)

Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib
por: Gravells, Polly, et al.
Publicado: (2018)

Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells
por: Zhang, Manqi, et al.
Publicado: (2020)

Purification of NAD(+) glycohydrolase from human serum
por: COŞKUN, ÖZLEM, et al.
Publicado: (2013)

Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells
por: Sasaki, Yuka, et al.
Publicado: (2022)

Investigation of the action of poly(ADP-ribose)-synthesising enzymes on NAD(+) analogues
por: Wallrodt, Sarah, et al.
Publicado: (2017)

Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a unique substrate-binding element
por: Kim, In-Kwon, et al.
Publicado: (2012)

Poly(ADP-ribose) glycohydrolase coordinates meiotic DNA double-strand break induction and repair independent of its catalytic activity
por: Janisiw, Eva, et al.
Publicado: (2020)

Poly(ADP‐ribose) glycohydrolase silencing‐mediated H2B expression inhibits benzo(a)pyrene‐induced carcinogenesis
por: Zeng, Zhuoying, et al.
Publicado: (2020)

Genomic and biological aspects of resistance to selective poly(ADP‐ribose) glycohydrolase inhibitor PDD00017273 in human colorectal cancer cells
por: Tsuda, Kaede, et al.
Publicado: (2022)

Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
por: Barazzuol, Lara, et al.
Publicado: (2013)

Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapy
por: Feng, Xiaoxing, et al.
Publicado: (2012)

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism
por: Rotin, Lianne E., et al.
Publicado: (2015)

A Novel Endogenous Inhibitor of the Secreted Streptococcal NAD-Glycohydrolase
por: Meehl, Michael A, et al.
Publicado: (2005)

NAD(+)-Glycohydrolase Promotes Intracellular Survival of Group A Streptococcus
por: Sharma, Onkar, et al.
Publicado: (2016)

Nicaraven induces programmed cell death by distinct mechanisms according to the expression levels of Bcl-2 and poly (ADP-ribose) glycohydrolase in cancer cells
por: Abdelghany, Lina, et al.
Publicado: (2022)

The tuberculosis necrotizing toxin is an NAD(+) and NADP(+) glycohydrolase with distinct enzymatic properties
por: Tak, Uday, et al.
Publicado: (2019)

Streptococcus pyogenes NAD+-Glycohydrolase Reduces Skeletal Muscle βNAD+ Levels Independently of Streptolysin O
por: McIndoo, Eric R., et al.
Publicado: (2022)

Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
por: Brosey, Chris A., et al.
Publicado: (2021)

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
por: Tentori, Lucio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t7n8kn5uger5iau9tsmuv3gtv0